CO-DIAGNOSTICS, INC.

Analyst Reco. Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
1.11 ^USD	-2.63%		-3.48%	-16.54%

04-12	Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	CI
04-04	Co-Diagnostics, Inc. Appoints Executive Appointments	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Co-Diagnostics to $3 From $2, Maintains Neutral Rating	11-13	MT
HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $3, Keeps Neutral Rating	14/08/23	MT
HC Wainwright Downgrades Co-Diagnostics to Neutral From Buy, Adjusts Price Target to $3 From $6	20/03/23	MT
HC Wainwright Adjusts Co-Diagnostics' Price Target to $9 From $12, Keeps Buy Rating	15/08/22	MT
Sidoti & Co. Downgrades Co-Diagnostics to Neutral From Buy, Lowers Price Target to $5 From $14	12/08/22	MT
HC Wainwright Adjusts Co-Diagnostics' Price Target to $12 From $15, Keeps Buy Rating	16/05/22	MT
Sidoti Initiates Coverage on Co-Diagnostics With Buy Rating, $14 Price Target	29/12/21	MT
CO DIAGNOSTICS : Maxim Downgrades Co-Diagnostics to Hold From Buy	29/03/21	MT
CO DIAGNOSTICS : HC Wainwright Adjusts Price Target on Co-Diagnostics to $16 From $30, Keeps Buy Rating	26/03/21	MT
CO DIAGNOSTICS : HC Wainwright Adjusts Co-Diagnostics' Price Target to $30 From $29, Reiterates Buy Rating	15/12/20	MT
Maxim Group & H.C. Wainwright Analysts Confirm Co-Diagnostics (NADSAQ:CODX) Buy Rating with PTs of $20 and $29	24/11/20	AQ
CO DIAGNOSTICS : HC Wainwright Adjusts Co-Diagnostics' Price Target to $29 From $33, Keeps at Buy	17/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer